Table 1.
Demographics, comorbidities, and infectious source by group.
| Characteristic | Physician diagnosis | Consensus criteria | p-value |
|---|---|---|---|
| N | 121 | 243 | |
| Age, mean in years (SD) | 51.4 (17.4) | 55.8 (17.4) | 0.03* |
| Do not resuscitate # (%) | 19 (16) | 18 (7) | 0.01* |
| Comorbidities # (%) | |||
| None | 8 (7) | 21 (9) | 0.5 |
| Alcohol abuse | 15 (12) | 27 (11) | 0.72 |
| Urinary catheter | 11 (9) | 5 (2) | < 0.01* |
| Vascular catheter | 5 (4) | 7 (3) | 0.53 |
| Congestive heart failure | 14 (12) | 29 (12) | 0.92 |
| Coronary artery disease | 15 (12) | 22 (9) | 0.32 |
| Myocardial infarction | 5 (4) | 13 (5) | 0.61 |
| Chronic obstructive pulmonary disease | 20 (17) | 48 (20) | 0.46 |
| Other lung disease | 13 (11) | 20 (8) | 0.43 |
| Dementia | 6 (5) | 3 (1) | 0.03* |
| Diabetes mellitus | 36 (30) | 58 (24) | 0.23 |
| Hypertension | 55 (46) | 85 (35) | 0.05 |
| Intravenous drug use | 13 (11) | 36 (15) | 0.28 |
| End stage liver disease | 7 (6) | 25 (10) | 0.15 |
| Chronic renal insufficiency | 25 (21) | 34 (14) | 0.1 |
| Hemodialysis | 4 (3) | 6 (3) | 0.65 |
| Stroke/transient ischemic attack | 10 (8) | 18 (7) | 0.77 |
| Solid malignancy | 22 (18) | 62 (26) | 0.12 |
| Hematologic malignancy | 8 (7) | 26 (11) | 0.21 |
| Human immunodeficiency virus | 3 (3) | 5 (2) | 0.8 |
| Metastatic cancer | 7 (6) | 18 (7) | 0.56 |
| Transplant | 4 (3) | 12 (5) | 0.47 |
| Infection source | |||
| Urine | 23 (19.0) | 35 (14.4) | 0.26 |
| Pulmonary | 46 (38.0) | 77 (31.7) | 0.23 |
| Skin/soft tissue | 26 (21.5) | 48 (19.8) | 0.7 |
| Abdominal | 11 (9.1) | 39 (16.1) | 0.07 |
| Viral | 5 (4.1) | 18 (7.4) | 0.23 |
| Blood | 21 (17.4) | 17 (7.0) | < 0.01* |
| Other | 15 (12.4) | 56 (23.1) | 0.02 |
SD, standard deviation.
Patients may have more than one infectious source identified during their stay.
*
denotes statistical significance of p < 0.05.